Paul B. Manning - 23 Feb 2026 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
26 Feb 2026, 19:38:59 UTC
Prior SEC filing
12 Feb 2026
Next SEC filing
02 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Charles Schoch, as Attorney-In-Fact for Paul B. Manning

Key filing fact

Paul B. Manning filed Form 4 for Candel Therapeutics, Inc. (CADL) on 26 Feb 2026.

Key facts

  • This page summarizes Paul B. Manning's Form 4 filing for Candel Therapeutics, Inc. (CADL).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 26 Feb 2026, 19:38.

Change

  • Previous filing in this sequence was filed on 12 Feb 2026.
  • Current net transaction value: +$2,999,996.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001494695 Primary reporting owner

Manning Paul B

Relationship
Director
Address
C/O CANDEL THERAPEUTICS, INC., 117 KENDRICK ST., SUITE 450, NEEDHAM
Signature
/s/ Charles Schoch, as Attorney-In-Fact for Paul B. Manning
Signature date
26 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CADL transaction

Common Stock

Purchase

Transaction value
$2,999,996
Shares
+550,458
Change %
+25%
Price
$5.45
Shares after
2,763,527
Date
23 Feb 2026
Ownership
By Paul B. Manning Revocable Trust
Footnotes
F1
CADL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,303,752
Date
23 Feb 2026
Ownership
By BKB Growth Investments, LLC
Footnotes
F2
CADL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,681,000
Date
23 Feb 2026
Ownership
Direct
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Footnote F2

The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Footnote F3

Includes shares held jointly with spouse.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .